Connect your AI

Agilon Health AGL Intangible Purchases

Intangible Purchases at other companies

Amneal Pharmaceuticals, Inc.AMRX

$7.85M+86.9%

Other financials

Income statement

Revenue$1.4B-7.3%

Operating income$4.0M+118%

Net income$48.9M+304%

EPS (diluted)$2.94+303%

Balance sheet

Cash & equivalents$211.6M+52.6%

Total debt$33.4M-20.5%

Total equity$181.4M-63.7%

Total assets$1.5B-22.1%

Cash flow

Operating cash flow$23.7M+174%

CapEx$3.1M-19.4%

Free cash flow$20.6M+158%

Valuation

Market cap$1.78B-92.6%

Enterprise value$1.61B-103%

P/S0.3×-3.8×

Profitability

Operating margin-7.5%+6.5pp

Net margin-6.1%+6.3pp

FCF margin-1.1%—

Returns & leverage

Return on equity-104%-291pp

Debt / equity0.2×+0.1×

Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Agilon Health's intangible purchases?: Agilon Health (AGL) reported intangible purchases of $25K in Q1 2026.
How has Agilon Health's intangible purchases changed year-over-year?: Agilon Health's intangible purchases decreased by 99.6% year-over-year, from $7.03M to $25K.
What is the long-term trend for Agilon Health's intangible purchases?: Over 4 years (2021 to 2025), Agilon Health's intangible purchases has grown at a 44.4% compound annual growth rate (CAGR), from $6.86M to $29.87M.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.